Grey Wolf Therapeutics secures $49M series B from Pfizer Venture Investments and EarlyBird VC

Health services Manufacturing Pharma

Investments

24 January 2023

Grey Wolf Therapeutics (company)

Health services Manufacturing Pharma

Total investments received (USD): 150.58m

Round value (USD): 49m

Round investors: Andera Partners Earlybird Venture Capital Oxford Science Enterprises Pfizer Venture Investments Canaan Partners British Patient Capital

Industry: Health services Manufacturing Pharma

Biotech Health services Manufacturing

Investments 14 July 2023

Health services Manufacturing

Investments 08 July 2023

Biotech Health services Manufacturing

Investments 21 June 2023

AI (big data) Biotech Competitive Intelligence Hardware Health services Manufacturing

Investments 18 June 2023

Biotech Health services Manufacturing Pharma

Investments 09 February 2023